Patients with CAD use clopidogrel could further reduce the risk of MACCE, MI, stroke, and BARC major bleeding, compared with the use of aspirin. This finding ...

The results of the current analysis showed no significant difference in clinical outcomes with ASA or clopidogrel monotherapy. All-cause mortality, cardiac ...

12 апр. 2023 г. · Clopidogrel could be considered over aspirin monotherapy regardless of the presence of diabetes in patients who have undergone coronary stenting.

17 апр. 2023 г. · The authors report that clopidogrel monotherapy was associated with a lower rate of the primary composite endpoint compared to aspirin monotherapy as long-term ...

By the 1-year landmark analysis, clopidogrel was numerically, but not significantly, superior to aspirin for cardiovascular events (6.79% and 8.68%, ...

11 нояб. 2024 г. · This supports the use of clopidogrel over aspirin in patients with CAD who require secondary prevention with long-term antiplatelet monotherapy.

31 авг. 2024 г. · Aspirin monotherapy compared with clopidogrel monotherapy was associated with similar cardiovascular and bleeding outcomes beyond 1 month and up ...

7 нояб. 2022 г. · Long-term treatment with clopidogrel monotherapy leads to a consistent reduction in cardiovascular events compared with aspirin monotherapy.

By the 1-year landmark analysis, clopidogrel was numerically, but not significantly, superior to aspirin for cardiovascular events (6.79% and 8.68%, ...

16 мая 2021 г. · Compared with aspirin, clopidogrel monotherapy was associated with a lower risk of the composite of all-cause death, non-fatal myocardial ...